B. Damdinsuren

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
B. Damdinsuren, Bazarragcha Damdinsuren, Bazarragchaa Damdinsuren
Publication record
67 papers · 2,808 citations · H-index 30

PAPERS

A controlled vocabulary and taxonomy for the submission of quality attributes for therapeutic proteins
20242 citationsauthor #3
Multi-Attribute Method for Quality Control of Therapeutic Proteins.
201999 citationsauthor #6
B cell receptor induced Fc receptor-like 5 expression is mediated by multiple signaling pathways converging on NF-κB and NFAT.
201611 citationsauthor #1
Human Fc receptor-like 5 interacts with key signaling proteins in B cells (P1116)
20130 citationsauthor #2
Human Fc Receptor–Like 5 Binds Intact IgG via Mechanisms Distinct from Those of Fc Receptors
201377 citationsauthor #2
This information is current as Receptors via Mechanisms Distinct from Those of Fc Like 5 Binds Intact IgG − Human Fc Receptor
20130 citationsauthor #2
Fc receptor‐like 5 promotes B cell proliferation and drives the development of cells displaying switched isotypes
201255 citationsauthor #4
Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4⁺ T cells to T-regulatory cells.
2011570 citationsauthor #2
Tumor immunity and immunosurveillance (PP-093)
20100 citationsauthor #133
Single round of antigen receptor signaling programs naive B cells to receive T cell help.
201071 citationsauthor #1
BCR mediated c-Rel induction facilitates NF-κB2 and RelB expression (84.22)
20100 citationsauthor #3
BCR mediated c-Rel induction facilitates NF-{kappa}B2 and RelB expression
20100 citationsauthor #3
Kinetic and function of c-Rel in naïve B cells (84.4)
20100 citationsauthor #1
Cancer cells utilize a novel regulatory subset of B cells to promote escape and metastasis (100.26)
20100 citationsauthor #2
B Cell Receptor-Mediated Sustained c-Rel Activation Facilitates Late Transitional B Cell Survival through Control of B Cell Activating Factor Receptor and NF-κB21
200951 citationsauthor #3
Aberrant Expression of Connexin 26 Is Associated with Lung Metastasis of Colorectal Cancer
200881 citationsauthor #5
Successful treatment of multiple hepatocellular carcinoma with tumor thrombi in the major portal branches by intraarterial 5-fluorouracil perfusion chemotherapy combined with subcutaneous interferon-alpha and hepatectomy
20076 citationsauthor #11
Hepatic resection followed by IFN-alpha and 5-FU for advanced hepatocellular carcinoma with tumor thrombus in the major portal branch.
200750 citationsauthor #9
Complete remission of hepatocellular carcinoma with portal vein tumor thrombus and lymph node metastases by arterial infusion of 5-fluorouracil and interferon-α combination therapy following hepatic resection
200710 citationsauthor #4
Stronger growth-inhibitory effect of interferon (IFN)-beta compared to IFN-alpha is mediated by IFN signaling pathway in hepatocellular carcinoma cells.
200732 citationsauthor #1
Patterns and clinicopathologic features of extrahepatic recurrence of hepatocellular carcinoma after curative resection.
2007227 citationsauthor #8
Overexpression of MT3-MMP in hepatocellular carcinoma correlates with capsular invasion.
200724 citationsauthor #11
Interferon alpha receptors are important for antiproliferative effect of interferon‐α against human hepatocellular carcinoma cells
200734 citationsauthor #1
Combination therapy of interferon-alpha and 5-fluorouracil inhibits tumor angiogenesis in human hepatocellular carcinoma cells by regulating vascular endothelial growth factor and angiopoietins.
200746 citationsauthor #7
Combined intra‐arterial 5‐fluorouracil and subcutaneous interferon‐alpha therapy for highly advanced hepatocellular carcinoma
200711 citationsauthor #1
Role of the Fas/FasL pathway in combination therapy with interferon-alpha and fluorouracil against hepatocellular carcinoma in vitro.
200761 citationsauthor #7
[Intra arterial infusion chemotherapy combined with interferon-alpha following palliative hepatic resection against advanced hepatoma with portal venous tumor thrombus in the major trunk and multiple nodules--a preliminary study].
20060 citationsauthor #7
[A successful case of hepatocellular carcinoma with portal venous tumor thrombus (Vp2) treated by transcatheter arterial chemoembolization].
20060 citationsauthor #5
Antisense to Cyclin D1 Inhibits Vascular Endothelial Growth Factor–Stimulated Growth of Vascular Endothelial Cells: Implication of Tumor Vascularization
200665 citationsauthor #4
Expression of PPARδ in multistage carcinogenesis of the colorectum: implications of malignant cancer morphology
200672 citationsauthor #3
Interferon alpha receptor-2c on cell membrane is important in antiproliferative effect of interferon-α against human hepatocellular carcinoma cells
20060 citationsauthor #1
A case of hepatocellular carcinoma with multiple lung, spleen, and remnant liver metastasis successfully treated by combination chemotherapy with the novel oral DPD-inhibiting chemotherapeutic drug S-1 and interferon-alpha.
20069 citationsauthor #6
Expression of type I interferon receptor as a predictor of clinical response to interferon-alpha therapy of gastrointestinal cancers.
200617 citationsauthor #9
A case of hepatocellular carcinoma with multiple lung, spleen, and remnant liver metastasis successfully treated by combination chemotherapy with the novel oral DPD-inhibiting chemotherapeutic drug S-1 and interferon-α
200614 citationsauthor #6
[Surgical treatment for peritoneal dissemination of hepatocellular carcinoma after percutaneous ethanol injection therapy--a case report].
20060 citationsauthor #4
Angiogenesis in cholangiocellular carcinoma: expression of vascular endothelial growth factor, angiopoietin-1/2, thrombospondin-1 and clinicopathological significance.
200689 citationsauthor #10
TGF-beta1-induced cell growth arrest and partial differentiation is related to the suppression of Id1 in human hepatoma cells.
200635 citationsauthor #1
Vitamin K2 has growth inhibition effect against hepatocellular carcinoma cell lines but does not enhance anti-tumor effect of combination treatment of interferon-alpha and fluorouracil in vitro.
20068 citationsauthor #6
Expression pattern of angiogenic factors and prognosis after hepatic resection in hepatocellular carcinoma: importance of angiopoietin‐2 and hypoxia‐induced factor‐1a
2006138 citationsauthor #10
Combination of IFN-α and 5-Fluorouracil Induces Apoptosis through IFN-α/β Receptor in Human Hepatocellular Carcinoma Cells
200560 citationsauthor #4
Expression of Id proteins in human hepatocellular carcinoma: relevance to tumor dedifferentiation.
200554 citationsauthor #1
Combination of IFN-alpha and 5-fluorouracil induces apoptosis through IFN-alpha/beta receptor in human hepatocellular carcinoma cells.
200532 citationsauthor #4
Role of p21waf1/cip1 in effects of oxaliplatin in colorectal cancer cells
200548 citationsauthor #6
Treatment of hepatocellular carcinoma with major portal vein thrombosis by combined therapy with subcutaneous interferon-α and intra-arterial 5-fluorouracil; role of type 1 interferon receptor expression
2005148 citationsauthor #8
Association Between Recurrence of Hepatocellular Carcinoma and α-Fetoprotein Messenger RNA Levels in Peripheral Blood
200542 citationsauthor #10
[A case of HCC with inferior caval vein tumor thrombus and multiple pulmonary metastases that remarkably responded to combination therapy of TS-1 and interferon-alpha].
20054 citationsauthor #9
[A successful surgical treatment for solitary pulmonary and adrenal metastases after hepatic resection to hepatocellular carcinoma--a case report].
20050 citationsauthor #7
Effects of p21cip1/waf1 overexpression on growth, apoptosis and differentiation in human colon carcinoma cells.
200512 citationsauthor #3
Methylation and expression of p16INK4 tumor suppressor gene in primary colorectal cancer tissues.
200541 citationsauthor #4
Pulmonary mucosa-associated lymphoid tissue type lymphoma with increased accumulation of fluorine 18-fluorodeoxyglucose on positron emission tomography.
200511 citationsauthor #5
Role of p 21 waf 1 / cip 1 in effects of oxaliplatin in colorectal cancer cells
20056 citationsauthor #6
PS-128-6 Interferon Alpha Receptor-2 and Anti-Tumor Effect of Type I Interferons in Hepatocellular Carcinoma Cells
20040 citationsauthor #1
[Successful treatment for advanced cholangiocellular carcinoma with intrahepatic metastasis and/or portal vein tumor thrombi by intraarterial chemotherapy combined with 5-fluorouracil, adriamycin and cisplatin (FAP)--two cases report].
20040 citationsauthor #9
[A case of long-term survivor with multiple pulmonary metastases of HCC after hepatic resection].
20044 citationsauthor #8
Partial Contribution of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)/TRAIL Receptor Pathway to Antitumor Effects of Interferon-α/5-Fluorouracil against Hepatocellular Carcinoma
200475 citationsauthor #7
Hepatic expression of ANG2 RNA in metastatic colorectal cancer
200457 citationsauthor #9
Interferon-β Is More Potent Than Interferon-α in Inhibition of Human Hepatocellular Carcinoma Cell Growth When Used Alone and in Combination With Anticancer Drugs
200359 citationsauthor #1
JTE-522, a cyclooxygenase-2 inhibitor, is an effective chemopreventive agent against rat experimental liver fibrosis1.
2003131 citationsauthor #9
508 Involvement of trail/trail receptor pathway in the anti-tumor effect of 5-fluorouracil and interferon-alpha therapy for hepatocellular carcinoma
20030 citationsauthor #4
519 The differences of the signaling and response to type I interferons in hepatocellular carcinoma cell lines
20030 citationsauthor #1
Interferon-beta is more potent than interferon-alpha in inhibition of human hepatocellular carcinoma cell growth when used alone and in combination with anticancer drugs.
200328 citationsauthor #1
Total synthesis of the antitumor acetogenin mosin B: desymmetrization approach to the stereodivergent synthesis of threo/trans/erythro-type acetogenins.
200331 citationsauthor #8
The role of Interferon alpha Receptor-2 in antiproliferative effect of type I Interferons and its methylation status in hepatocellular carcinoma cell lines
20030 citationsauthor #1
527 The meaning of protocadherin LKC expression in hepatocellular carcinoma
20030 citationsauthor #6
Total Synthesis of the Antitumor Acetogenin Mosin B (I): Desymmetrization Approach to the Stereodivergent Synthesis of threo/trans/erythro‐Type Acetogenins.
20030 citationsauthor #8
PP-2-376 Effects of IFN-α and-β in combination with anti-cancer drugs in HCC cell lines
20020 citationsauthor #1
PP395 Expressions of Id(Inhibitor of DNA binding/differentiation)1, 2, 3 in HCC
20010 citationsauthor #1

TIMELINE

2001 0 citations

2002 0 citations

2003 249 citations

2004 136 citations

2005 458 citations

2006 447 citations

2007 501 citations

2008 81 citations

2009 51 citations

2010 71 citations

2011 570 citations

2012 55 citations

2013 77 citations

2016 11 citations

2019 99 citations

2024 2 citations

COAUTHOR MAP

CONCEPT FOOTPRINT